Comparing motor outcomes in two Parkinson’s trials · Version 1
A Waddell evidence pilot compares the primary motor assessments in LIXIPARK and Exenatide-PD3. It documents medication state, analysis counts, follow-up, and the editorial notice for Exenatide-PD3.
Open protocol and evidence